Clinical Trials Directory

Trials / Completed

CompletedNCT06503770

A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) Post Lung Transplantation

Status
Completed
Phase
Study type
Observational
Enrollment
284 (actual)
Sponsor
Zambon SpA · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to describe the forced expiratory volume in 1 second (FEV1) decline and natural disease evolution in patients affected by CLAD-BOS after lung transplantation and receiving an immunosuppressive therapy as standard of care.

Detailed description

This is a retrospective, multinational, multicenter chart review study of adult patients with clinically diagnosed CLAD-BOS after lung transplantation. All data will be retrospectively collected from patient records starting from lung transplantation date through last date of available data, and as such, no interventions will be applied as part of this study. The observational period for each patient will be from lung transplant date until last date of data available or death, whichever occurs earlier and will include the following time periods: Diagnosis window: 01 January 2013 through most recent data available.

Conditions

Timeline

Start date
2024-06-27
Primary completion
2025-04-02
Completion
2025-04-02
First posted
2024-07-16
Last updated
2025-05-20

Locations

6 sites across 3 countries: United States, Belgium, Spain

Source: ClinicalTrials.gov record NCT06503770. Inclusion in this directory is not an endorsement.